Latest News

Shake Shack (SHAK) has been under pressure after first quarter results fell short on earnings and revenue, producing a rare operating loss as higher costs and regional disruptions weighed on profitability. See our latest analysis for Shake Shack. The sharp post earnings selloff is clear in the 7 day share price return of down 26.61% and 30 day return of down 28.87%. The 1 year total shareholder return of down 37.93% shows pressure has been building for some time, despite a new CFO appointment...

Franklin Electric (FELE) is back in focus after reporting first quarter 2026 results and reaffirming its full year net sales guidance, prompting investors to reassess the stock’s risk and income profile. See our latest analysis for Franklin Electric. At a share price of $99.34, Franklin Electric’s short term share price performance has been mixed, with the stock down 8.35% over 90 days but supported by a 1 year total shareholder return of 11.99%, suggesting momentum has cooled after earlier...

Why NSK (TSE:6471) is on investors’ radar today NSK (TSE:6471) has attracted fresh attention after its recent share price move, with the stock up 1.9% on the day and showing stronger performance over the past month. This shift comes against a backdrop of ¥858,210 in revenue and ¥20,259 in net income. These figures provide a starting point to think about how the current ¥1,360 share price lines up with fundamentals. See our latest analysis for NSK. That 1.9% move in the share price fits into a...

In early May 2026, Diebold Nixdorf reported first-quarter revenue of US$891.8 million and net income of US$5 million, while VyStar Credit Union expanded its partnership to adopt Diebold Nixdorf's Branch Automation Solutions and upgrade more than 200 ATMs with DN Series cash-recycling devices and advanced software features. The VyStar rollout highlights how Diebold Nixdorf’s artificial intelligence-driven managed services and analytics are being embedded deeper into client ATM networks,...

Key earnings details from Northeast Bank’s latest report Northeast Bank (NBN) posted third quarter results that highlighted year over year changes in profitability, including net interest income of US$63.07 million and net income of US$29.85 million for the period ended March 31, 2026. For the first nine months of the fiscal year, the bank reported net interest income of US$160.07 million and net income of US$73.14 million, giving investors fresh data to assess recent performance and earnings...

Ambarella recently announced that its co‑founder, president and CEO, Fermi Wang, received the inaugural 2026 IEEE Arun N. Netravali Video Analytics, Technology and Systems Award for his work in AI-powered video and edge analytics, underscoring the company’s technical contributions to this field. This recognition puts fresh attention on Ambarella’s edge AI system-on-chip platforms, highlighting how leadership in video analytics and AI processing underpins its semiconductor offering. We’ll now...

In early May 2026, Neurocrine Biosciences reported first‑quarter revenue of US$814.5 million and net income of US$197.9 million, alongside multiple clinical and real‑world updates for its endocrine and neuroscience portfolio, including CRENESSITY and a new obesity candidate NBIP‑’2118. Beyond the headline numbers, the first expert dosing algorithms and two‑year pediatric data for CRENESSITY suggest growing medical integration of the therapy in classic congenital adrenal hyperplasia care,...

Relay Therapeutics, Inc. recently reported first-quarter 2026 results showing revenue of US$3.00 million and a net loss of US$73.29 million, while outlining plans to advance its lead PI3Ka inhibitor zovegalisib with Pfizer’s atirmociclib into Phase 3 for frontline PI3Ka‑mutated, HR+/HER2- metastatic breast cancer. What stands out is that in heavily pre-treated patients, the zovegalisib triplet regimen showed an objective response rate approaching current first-line doublet therapies, which...

Procore Technologies (PCOR) is back in focus after its first quarter 2026 update, which combined higher revenue, a narrower net loss, raised full year guidance, fresh AI moves, and active share repurchases. See our latest analysis for Procore Technologies. Despite the stronger first quarter story and raised 2026 guidance, Procore Technologies' share price return is down 23.9% year to date and total shareholder return is down 26.2% over the past year. The 1 month share price return of 12.9%...

Sirius XM Holdings Inc. reported past first-quarter 2026 results, with revenue of US$2,091 million and net income of US$245 million, alongside higher basic and diluted earnings per share than a year earlier. A new advertising partnership with YouTube, allowing buyers to access YouTube’s audio inventory through Sirius XM’s adtech platform, signals a meaningful shift in how the company can monetize digital audio audiences. We’ll now examine how the YouTube ad partnership, alongside stronger...

Macmahon Holdings Limited recently appointed Mr. Arief Sidarto, President Director of its largest shareholder PT Amman Mineral Internasional Tbk, as a Non-Independent, Non-Executive Director effective 29 April 2026, marking his return to the board after previously serving from August 2017 to July 2023. With Amman now exercising its right to nominate two directors, investors may read Mr. Sidarto’s reappointment as a signal of deeper shareholder influence and tighter alignment between Macmahon...

In early May 2026, Draganfly Inc. announced new Flex FPV drone selections by two additional U.S. Department of War units and revealed it will report Q1 2026 results and host a shareholder update call after market close on May 11, 2026. Draganfly also disclosed an exclusive master distributor agreement with Japan’s ACSL to bring NDAA-compliant SOTEN drones to Canada and integrate both companies’ platforms, aiming to create interoperable fleets as the country’s commercial drone market moves...

Globant (NYSE:GLOB) is back in focus after a series of securities class action lawsuits alleged the company misled investors about its Latin American pivot, operational challenges, and subsequent restructuring. See our latest analysis for Globant. At a share price of US$39.23, Globant’s recent 1 day share price decline of 4.25% extends a weaker run, with the 30 day share price return down 9.32% and the 1 year total shareholder return down 71.65%. This suggests momentum has faded as investors...

In late April 2026, Brown-Forman Corporation announced it had realigned its U.S. control states distribution network, appointing four key distributors across 11 state-managed spirits markets while retaining existing partners in seven others. This reshaping of distributor relationships, following the end of merger discussions with Pernod Ricard, signals Brown-Forman’s focus on sharpening operational efficiency and market reach. We’ll now examine how this control states distribution overhaul...

Earnings jump and dividend plans put TOTO (TSE:5332) in focus TOTO (TSE:5332) is back on many investors’ screens after full year results to March 31, 2026, and a board meeting on dividends coincided with a sharp pickup in trading activity. For the year, TOTO reported sales of ¥737,441 million and net income of ¥40,257 million, with basic earnings per share from continuing operations at ¥243.01 and diluted earnings per share at ¥242.91. See our latest analysis for TOTO. The share price has...

Sony Group (TSE:6758) has formed a joint venture with TSMC in Japan to develop and manufacture next generation image sensors. The partnership targets advanced sensor demand from applications such as AI, vehicles, and robotics. The move aligns with Sony's shift toward content, sensors, and IP driven businesses and away from lower margin hardware manufacturing. Sony Group, trading at around ¥3,372.0, sits at an interesting point in its stock performance. The share price is up 7.8% over the...

Alvotech recently reported first-quarter 2026 results showing net income of US$1.03 million compared with US$109.68 million a year earlier, alongside a prior revenue decline tied to production slowdowns and facility improvements. Days later, the FDA completed a routine cGMP surveillance inspection of Alvotech’s Reykjavik site and issued a Form 483, which the company says involves remediable observations and supports its plan to resubmit key Biologics License Applications in 2026. We’ll now...

A federal judge’s dismissal of a securities lawsuit against MINISO Group Holding (MNSO) removes a legal overhang that had focused on its retail partner model and is prompting investors to reassess the stock’s recent underperformance. See our latest analysis for MINISO Group Holding. At a share price of US$14.63, the stock has seen short term pressure, with a 30 day share price return down 7.52% and a 90 day share price return down 23.92%. This feeds into a 1 year total shareholder return down...

Wondering whether NIKE at around US$44.14 is a bargain or a value trap? This article breaks down what the current price actually reflects. The stock has edged up 2.4% over the past week and 3.6% over the past month, yet is still down 30.2% year to date and 27.7% over the last year. Longer term 3 year and 5 year returns are also in decline at 61.0% and 65.1% respectively. Recent attention on NIKE has focused on how its share price performance compares with wider consumer durables stocks and...

Canadian Pacific Kansas City (TSX:CP) is back in focus after upgrading its Southeast Mexico Express premium intermodal service with CSX by introducing a dedicated train and shorter transit times between key U.S. and Mexican markets. See our latest analysis for Canadian Pacific Kansas City. The new SMX service upgrade comes after a busy few weeks for Canadian Pacific Kansas City, including first quarter earnings, a dividend increase, share repurchases and upcoming investor conference...

Wondering whether AGI at around US$7.01 is a bargain or a value trap? This article walks through the key valuation clues that can help you frame that question. Over the last week the stock gained 2.9%, while over the past month it fell 1.3% and year to date it is down 34.8%. This naturally raises questions about how the market is currently pricing its prospects and risks. Recent coverage has focused on AGI's position in the US banking sector and how its share price has reacted to shifts in...

GSK (LSE:GSK) has entered an exclusive collaboration with Sino Biopharmaceutical, focused on bepirovirsen, a potential first in class hepatitis B treatment for the Chinese market. The partnership aims to accelerate the launch of bepirovirsen in China, targeting a large population affected by chronic hepatitis B. The agreement combines GSK’s R&D in hepatitis B with Sino Biopharmaceutical’s local healthcare presence to expand patient access. For GSK, which is focused on vaccines and specialty...

Melco Resorts & Entertainment (MLCO) is back on investors’ radar after reporting Q1 2026 results, with higher sales, revenue, and net income compared with a year earlier, along with fresh share repurchase activity. See our latest analysis for Melco Resorts & Entertainment. The recent Q1 results and new US$500 million buyback plan have arrived after a tougher stretch for investors, with the stock’s year to date share price return down 28.5% and the 1 year total shareholder return down 14.1%...

In the first quarter of 2026, Colgate-Palmolive reported sales of US$5,324 million, up from US$4,911 million a year earlier, while net income eased to US$646 million from US$690 million and diluted EPS slipped to US$0.80 from US$0.85. Despite pressure on margins from higher input costs, management kept its full-year 2026 net sales growth outlook of 2% to 6%, signaling confidence in its pricing and volume strategy across key markets. We’ll now examine how this combination of stronger sales,...